cp wire

CP Wire Articles

According to this regulatory filing, Pappas has raised a new $85.7 million investment... read more

Thu, 01/17/19 - 09:35 am
  • Erleada is also approved in the US for the treatment of non-metastatic castration-resistant prostate cancer

The Janssen Pharmaceutical Companies of Johnson & Johnson... read more

Wed, 01/16/19 - 09:52 am
  • Facility will officially open in 1Q 2019
  • Ph I/II study on KB103 interim results met primary and secondary endpoints

Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS... read more

Tue, 01/15/19 - 09:51 am
  • The tafamidis meglumine form (20 mg capsule) has been granted Priority Review

  • Tafamidis was granted Orphan Drug Designation for ATTR-CM in both the EU and US in 2012

... read more

Mon, 01/14/19 - 10:09 am
Cresskill, NJ.  Vascular Therapies, a biotechnology company focused on improving outcomes for patients with advanced kidney disease today announced the appointment of John... read more
Thu, 01/10/19 - 03:22 pm

Numerate, Inc. announced on 1/7/19 a multi-target research collaboration with Lundbeck Pharmaceutical to identify clinical candidates for the treatment of disorders in the central nervous system,... read more

Mon, 01/7/19 - 10:05 am

Atlantic Therapeutics announced on 1/7/19 that it has closed €28 million in Series B funding to continue its rapid growth trajectory.
Having recently gained FDA clearance for its INNOVO® ... read more

Mon, 01/7/19 - 09:48 am

Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress conditions announced on 1/4/19 the closing of a $... read more

Fri, 01/4/19 - 09:13 am

Ablative Solutions, Inc. announced on 1/3/19 the first close of its $77 million Series D funding round. The round was led by new investor Gilde Healthcare and co-led by existing investor BioStar... read more

Thu, 01/3/19 - 09:50 am

Wave Life Sciences Ltd. (NASDAQ: WVE announced on 1/3/19 that the planned Phase 2/3 efficacy and safety trial for its lead Duchenne muscular dystrophy (DMD) clinical program has been selected for... read more

Thu, 01/3/19 - 09:41 am

Myonexus Therapeutics, announced today that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation for MYO-102, a novel gene therapy candidate for alpha-... read more

Wed, 01/2/19 - 09:54 am

Atlas Venture, a leading venture capital firm investing in breakthrough biotech innovation, today announced the closing of its first Opportunity Fund, raising $250 million in an oversubscribed... read more

Wed, 01/2/19 - 09:46 am

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pfizer Inc. (NYSE: PFE) today announced that the Phase 3 ARCHES trial evaluating Xtandi (enzalutamide)... read more

Thu, 12/20/18 - 10:19 am

On 12/20/18, Relay Therapeutics announced the successful completion of a $400 million Series C financing.

Relay Therapeutics combines unprecedented computational power with leading... read more

Thu, 12/20/18 - 09:57 am

Equillium, Inc. (Nasdaq: EQ) announced on 12/19/18 that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for EQ001 for the treatment of acute graft-versus-host... read more

Wed, 12/19/18 - 10:15 am

Auron Therapeutics and Elucidata Corporation on 12/19/18 announced a scientific collaboration using Elucidata’s AI-based target discovery platform to identify and validate targets for... read more

Wed, 12/19/18 - 10:00 am

Annexon Biosciences, a clinical stage biopharmaceutical company focused on the development of novel therapeutics through inhibition of the classical complement pathway, announced on 12/19/18 that... read more

Wed, 12/19/18 - 09:39 am

Versant Ventures announced on 12/17/18 that it raised USD100 million for a Canadian fund called Versant Voyageurs I. Voyageurs will be deployed across five to eight startup companies with Canadian... read more

Mon, 12/17/18 - 11:02 am


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.